HCA Healthcare (NYSE:HCA) Releases Earnings Results, Beats Estimates By $0.53 EPS

HCA Healthcare (NYSE:HCA) announced its earnings results on Tuesday. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53, Briefing.com reports. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter in the previous year, the business earned $4.29 EPS. The company’s quarterly revenue was up 10.3% on a year-over-year basis. HCA Healthcare updated its FY 2024 guidance to 21.600-22.800 EPS.

HCA Healthcare Stock Performance

NYSE HCA opened at $352.79 on Friday. The stock has a market capitalization of $92.40 billion, a price-to-earnings ratio of 17.59, a PEG ratio of 1.38 and a beta of 1.68. HCA Healthcare has a twelve month low of $215.96 and a twelve month high of $356.30. The company has a current ratio of 1.06, a quick ratio of 1.02 and a debt-to-equity ratio of 27.11. The stock has a 50-day moving average of $329.48 and a 200 day moving average of $322.74.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.75%. HCA Healthcare’s payout ratio is 13.16%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft boosted their price objective on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Robert W. Baird started coverage on HCA Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price target for the company. Baird R W raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, SVB Leerink boosted their price target on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday. Four investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $339.72.

Insider Buying and Selling

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of the stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the transaction, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of the stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the transaction, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 973 shares of the stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The disclosure for this sale can be found here. In the last 90 days, insiders sold 12,397 shares of company stock valued at $3,921,929. 1.60% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.